Sulphonamides for the treatment of central nervous system diseases
CA 2426977 A1 · Owner: Bayer Aktiengesellschaft · Inventors: Wirtz, Stephan-Nicholas; Boss, Frank-Gerhard; Bruggemeier, Ulf
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the use of sulphonamides for the production of a medicament for the prophylaxis and/or treatment of diseases which may be treated with a 5-HT6 antagonist, in particular diseases of the central nervous system.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 19, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 19, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 19, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.